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 Abstract 
 This study aimed to examine the integrity of the ear canal skin and its microbiological chang-
es caused by an extended-wear hearing device. An extended-wear hearing device, Lyric2 
(Phonak AG, Switzerland), which is the second generation of the Lyric device, was fitted to 52 
ears of 27 subjects. A refit of the device was done for a selection of ears (n = 15) for which the 
initial fitting was interrupted (28 ears). A matching control group consisted of 10 ears of 10 
subjects with no history of using any form of hearing aid for 3 months. The ear canal skin of 
ears fitted with the hearing device was inspected using an otoendoscope, and signs of prob-
lematic pathological conditions were graded. Microbiological examinations were performed 
at three different stages following fitting. Wearing the device was interrupted in 28 (53.8%) 
out of the 52 ears for the initial fitting, and 17 of the 28 interrupted cases (60.7%) were due to 
issues of the ear canal skin. In 3 of 15 ears (25%) following a refitting, wearing the device was 
interrupted yet again, and 1 of these 3 interruptions was caused by ear canal skin pathologies. 
Growth of bacteria was not enhanced or prompted by wearing the Lyric2, and Gram-negative 
bacteria could not be cultured while the device was in place. Based on aspects of ear canal 
skin pathology, continuous and nonproblematic uses of the Lyric2 device are presumed to be 
obtained if the fitting is done carefully. Wearing of the Lyric2 device can be considered safe 
from a microbiological perspective and does not promote growth of Gram-negative bacteria. 
 © 2014 S. Karger AG, Basel 
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 Introduction 
 While various types of hearing aids have provided benefits to individuals with hearing 
loss, most current hearing aids still have drawbacks such as dissatisfaction with the quality 
of sound, the occlusion effect (autophony), comfort, and visibility [Branda, 2012]. In addition, 
people often object to the daily routines associated with hearing aid use such as daily insertion 
and removal, replacement of batteries, telephone and earphone usage, wind noise, and 
problems associated with cerumen [Kochkin, 2007].
 In an attempt to resolve such traditional drawbacks of hearing aids, extended-wear 
hearing devices have been designed. These are positioned deep into the external auditory 
canal (e.g. Lyric, Phonak AG, Switzerland;  fig. 1 ). Insertion of such a device is usually performed 
by a trained hearing health care professional, and the device remains in situ for up to 120 days 
without further maintenance. Positioned millimeters laterally from the tympanic membrane, 
the device sits mostly in the bony part of the external auditory canal. The benefits of the 
extended-wear hearing device include its total invisibility, its ability to provide continuous 
full-time hearing support without daily handling and maintenance such as regular cleaning 
or battery exchange, minimal occlusion due to its deep placement in the ear canal [Gudmundsen, 
1994; Branda, 2012], and the ability to hear during sleep.
 Such extended-wear hearing devices need to fulfill various requirements with regard to 
biocompatibility and pressure applied to the skin as well as environmental properties such 
as breathability and moisture transport in order to maintain a healthy physiological condition 
of the ear canal. Fitting and wearing the extended-wear hearing device may cause changes of 
the physiological status of the ear canal skin, possibly leading to discomfort, at which point 
the subject, along with professional guidance, must decide if continuation of device use is 
warranted. Further, if significant problems are observed on the ear canal skin, the device 
should be removed even if the subject is not feeling discomfort.
 One specific difference between a conventional and an extended-wear hearing instrument 
is that with the latter, the external ear canal is continuously occluded. Occlusion by a device 
may increase the relative humidity of the inner part of the auditory canal which in turn may 
 Fig. 1. Schematic visualization of 
the deep-fitted Lyric2 device 
(Phonak AG, Switzerland) in the 
ear canal. 
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make the area more prone to infection. It has been shown that occlusion of the ear canal by 
conventional hearing aids does increase the number of microorganisms, and an increase in 
the number of pathogenic bacteria accompanied by skin maceration could promote an 
infection [Brook and Coolbaugh, 1984; Karaca et al., 2013]. Although more open-fit hearing 
aids allow a certain amount of humidity transport and compensation of static pressure 
changes, it is still questionable whether occlusion by any portion of the hearing device affects 
the microbiology in the ear canal.
 This study aimed to investigate issues related to ear canal health in subjects fitted with 
an extended-wear hearing device, Lyric2 (Phonak AG, Switzerland), which is the second 
generation of the Lyric device, featuring a smaller size in both length and diameter to increase 
the anatomic fitting rate. The study focused on three aspects: (a) integrity of the ear canal skin 
during the use of the extended-wear hearing device, (b) relationship between the integrity of 
the ear canal skin and continuation of wearing the device, and (c) potential change of the 
microbiological status in the skin flora with longer-term use.
 Materials and Methods 
 Subjects and Wearing Duration of Lyric2 
 The study was approved by the local ethics committee (ref. No. KEK-ZH-Nr. 2011-0186). 
Fifty ears of 26 subjects (20 males and 6 females) with mild-to-moderate hearing loss were 
included in this study. For inclusion in the study, 40 subjects from the internal database of the 
validation team at Phonak AG were screened. They were chosen according to their hearing 
loss (they had to match the fitting range of Lyric2) and sized for Lyric2. If the sizing was 
successful, they were invited to participate in the study. The Lyric2 device was placed binau-
rally for 24 subjects and monaurally for 2 subjects who had a monaural hearing loss. The 
average age of the subjects was 59 years with a range from 22 to 87 years. The subjects were 
self-selected and received otolaryngological and audiological evaluation before the fitting, in 
order to confirm candidacy criteria [Arbogast, 2010]. These criteria included aspects of life-
style (for instance, exclusion of scuba divers and sky divers), range of hearing loss, medical 
history (i.e. healthy outer and middle ear), and ear canal geometry. The Lyric2 is intended to 
be placed 4 mm from the tympanic membrane and initial placement complied with this 
requirement. However, slight changes of the device location were allowed at the time of the 
fitting if the change was helpful for the subject’s comfort. Fittings were performed by audi-
ologists in the audiology clinic at Phonak AG, who were trained for the fitting of the Lyric 
device. An ENT physician from the University Hospital Zurich also participated in the prein-
spection and in the examination of other aspects of the fitting.
 Whenever the result of the first fitting was not satisfactory, a refitting was done if the 
subject agreed. The reasons for the refitting included: (a) technical issues of the device and 
(b) clinical issues such as the subject’s discomfort and observation of signs of significant path-
ological conditions in the ear canal skin (grade 2; see the section ‘Inspection of ear canal skin’) 
as well as occlusion, migration of the device, and sound quality. While immediate and simple 
replacement of the device was chosen due to technical problems of the device, the refitting 
procedure for cases with clinical issues included inspection of ear canal integrity, change of 
the device size and/or readjustment of insert depth. When a replacement was due to a signif-
icant pathological condition in the ear canal skin with signs of grade 2 ( table 1 ), device use 
was discontinued for 2 weeks and the pathological condition had to be resolved. Because the 
focus of this study was on the integrity and microbiological conditions of the ear canal and 
their clinical importance, simple replacement of the device due to technical issues was not 
included in the descriptive statistics concerning refitting due to clinical reasons.
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 Inspection of Ear Canal Skin 
 The ear canal skin was evaluated using an otoendoscope to determine any signs of 
pathology specifically erythema, edema, exudation, and ulcer. The severity of the pathological 
signs was graded according to three levels (0 = none, 1 = mild, and 2 = significant; see  table 1 
for complete descriptions of these categories).  Figure 2 displays examples of ear canal skin that 
would be classified as having mild signs, grade 1 ( fig. 2 a), and significant signs, grade 2 ( fig. 2 b).
 After the initial fitting, the ear was inspected while the device was removed temporarily 
(i.e. the device was removed only during the inspection and was fitted again immediately 
after the inspection was done) at (a) 3–5 days (1st inspection) and (b) 10–14 days (2nd 
inspection). When a refitting was done, the 1st and 2nd inspections were repeated. The ear 
canal was also inspected at least 50 days after the fitting for those subjects who continued to 
use the device. Extra examinations were done if any discomfort was reported by subjects.
 Correlation between Ear Canal Skin Integrity and Continuation of Wearing Lyric2 
 All cases were classified as being either ‘successful’ or ‘unsuccessful’ depending upon the 
total duration of the wear. While the longest possible use period of the device was 120 days 
from the expected life time of the battery, cases wearing the device for more than a half of the 
maximum (i.e. 60 days) were considered as ‘successful’, and all other cases were classified as 
‘unsuccessful’. The ‘successful’ cases included those that reached the required wearing 
duration (i.e. 60 days) with the first fitting (‘successful’ without refitting) and cases that failed 
Symptom  Grade
 0 1 2
Erythema none mild significant
Edema none mild significant
Exudation none dry moist
Ulcer none pressure mark ulcer
 Table 1.  Pathological signs on 
the ear canal skin and their grade
a b
 Fig. 2. Examination of pathological signs on the ear canal skin.  a Ear canal skin with mild signs (grade 1; dry 
exudation and pressure mark observed).  b Ear canal skin with severe signs (grade 2; moist exudation, sig-
nificant edema, and ulcer observed). 
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with the first fitting but reached the required wearing duration with the refitting (‘successful’ 
with refitting). The ‘unsuccessful’ cases included those that failed with the first fitting and for 
whom refitting was not performed (‘unsuccessful’ without refitting) and cases who failed 
even with the refitting (‘unsuccessful’ with refitting). For all classifications (i.e. ‘successful’ 
without refitting, ‘successful’ with refitting, ‘unsuccessful’ without refitting, and ‘unsuc-
cessful’ with refitting), the integrity of the ear canal skin (see section ‘Inspection of ear canal 
skin’) was analyzed as a factor determining continuation of device use.
 Microbiological Investigations 
 Microbiological examinations were performed at three different stages: (a) prior to the 
fitting (on the same day as the fitting), (b) 10–14 days after the fitting (together with the 2nd 
inspection of ear canal skin pathology; see section ‘Inspection of ear canal skin’), and (c) the 
end of the first period of wearing the device before it was changed – only for ‘successful’ cases 
(i.e. at least 60 days after the fitting; see section ‘Correlation between ear canal skin integrity 
and continuation of wearing Lyric2’). Specimens were obtained from two locations in the ear 
canal with a commercial thin sterile transport swab that was inserted into the corresponding 
standard transport tube with Amies agar without charcoal (110C.USE AMIES W/O CH, Copan, 
Brescia, Italy). The first location was slightly toward a site lateral to the end of the Lyric2 
device (denoted as ‘lateral’ location) and the second slightly medial to the medial end of the 
Lyric2 device (denoted as ‘medial’ location), thus corresponding to the outer and inner sides 
of the Lyric2 device as it sits in the ear canal. The device was removed and the auditory canals 
were swabbed gently by rolling the swabs 360°. The collected swabs were sent to the micro-
biological laboratory (Institute of Medial Microbiology, University of Zurich) within 8 h. 
Before each swab, an otoscopic examination was performed to ensure that there was no 
active ear disease. The device was replaced after the specimens had been obtained.
 Specimens were inoculated semiquantitatively onto Columbia sheep blood (5%) agar 
plates (BioMérieux, Marcy l’Etoile, France), Columbia sheep blood (5%) agar plates with 
colistin and nalidixic acid (BioMérieux) and MacConkey agar plates (BioMérieux). Growth of 
colonies was interpreted as little, moderate and numerous, but for the results, any growth of 
a species or a group of bacteria, i.e. coagulase-negative staphylococci or  Corynebacterium 
spp., was equally registered. Bacteria were identified according to standard laboratory proce-
dures by Versalovic et al. [2011].
 The first microbiological test (prior to the fitting) was performed for 41 ears of 21 subjects 
because the required tests were not available when the study was started. Eight additional 
ears were evaluated at the second microbiological examination (10–14 days after the fitting). 
Among the 41 ears for which the first microbiological test was performed, 25 were still 
wearing the device at the second microbiological test, and 13 at the third microbiological test 
(more than 60 days after the fitting), without discontinuation of wearing the device. Among 
the 8 ears that were added to the second microbiological test, only 2 ears kept wearing the 
device without discontinuation and were evaluated at the third microbiological examination. 
As a consequence, all the 1st, 2nd, and 3rd inspections were performed only for 13 ears, and 
1 or 2 out of the 3 examinations were missed for other ears. The total range of the microbio-
logical tests is illustrated in  figure 3 .
 The same microbiological tests were also performed for the control group, which consisted 
of 10 subjects who were chosen among the R&D crew at Phonak AG, and had no history of using 
any form of hearing aids for 3 months prior to obtaining the specimens. The average age of the 
control group members was 47 years (range from 35 to 59 years), and the gender distribution 
was 4 males and 6 females. The swab samples were taken from one side with the two different 
locations in the ear canal (lateral and medial), which corresponded to the same locations in the 
study group. The microbiological tests were performed only once for the control group.
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 Statistical calculation was performed for comparison of the results of the microbiological 
examinations between the different inspection periods and for comparison between each of 
the test periods in the study group and the control group. For each bacterium observed, the 
McNemar test was used for comparison between the different test periods in the study group, 
and the Fisher exact test was used for comparison between each of the test periods in the 
study group and the control group. Because the existence of Gram-negative bacteria was a 
focus in the microbiological investigation of the study (see Discussion), the specimens were 
classified into three categories: (a) existence of Gram-negative bacteria, (b) existence of 
Gram-positive bacteria only, and (c) no bacteria. The signed rank test was used for comparison 
between the different test periods for each of the classifications to determine development, 
and the Mann-Whitney test was used for comparison between the study group and control 
group. Differences with a p value of <0.05 were considered as the level of statistical signifi-
cance.
 Results 
 Inspection of Ear Canal Skin 
 Table 2 lists the results of the follow-up inspections of the ear canal during the first fitting 
and refitting of the devices, and long-term inspections in ears that were fitted successfully. 
During the first fitting, 75% of the inspected ears showed signs of erythema, edema, exudation, 
and/or ulcer in the 1st follow-up inspection (3–5 days after the first fitting), and such signs 
were observed in 55.2% of the inspected ears in the 2nd follow-up inspection (10–14 days 
after the first fitting). The reduced percentage in the 2nd follow-up inspection may be 
explained by the fact that those subjects who exhibited significant signs (grade 2 in  table 1 ) 
or mentioned discomfort during the first inspection were told to stop using the device. Such 
a trend was also shown in the cases that were refit. During the refitting, these signs were 
Prior to fitting
41 ears
16 ears
Stop wearing
2nd test
(n = 33)
10–14 days
after fitting
25 ears
12 ears
Stop wearing
3rd test
(n = 15)
>60 days
after fitting
13 ears
8 ears
6 ears
Stop wearing
2 ears
1st test
(n = 41)
 Fig. 3. Course of microbiological tests. The first microbiological test (prior to the fitting) was performed for 
41 ears from 21 subjects, and 8 ears were added in the second microbiological examination (10–14 days af-
ter the fitting). All 3 inspections were only performed for 13 ears, and 1 or 2 of the 3 examinations were miss-
ing for the other ears because the subjects did not keep wearing the device. 
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observed in 69.2% of the 1st follow-up inspections and in 37.5% of the 2nd follow-up inspec-
tions. At the end of the long-term use for ears successfully retaining the device, observation 
of pathological signs in the ear canal skin still occupied a larger portion (32%), but all signs 
were mild (grade 1 in  table 1 ).
 Table 3 lists the classification of findings by grade (0, 1, and 2), where an ear was placed 
in the highest category if any physiological signs were observed, based on the severity of the 
condition. Such a classification was based on the fact that existence of grade 2 signs rather 
than the number of types of signs determined continuation of wearing the device. Grade 2 was 
observed most often in the 1st follow-up inspection after the initial fitting and was observed 
only in 1 ear in the first inspection during the refitting. Grade 2 was not observed in any of 
the long-term inspections. Grade 1 occupies the highest proportion except for the 2nd 
inspection during the refitting, where grade 0 (no symptom) was mostly observed. Overall, 
95% of the ears during the various inspections were classified as grades 0 or 1 and were thus 
judged fit for immediate refitting and continuous use of the device, whereas in 5%, there were 
observations with signs of grade 2 and the use of the device was interrupted.
 The locations of the pathological signs in the ear canal as a function of the type of sign are 
shown in  table 4 . Erythema was seen mostly in the medial posterior region (17 ears), and also 
occurred considerably in the medial inferior region (10 ears). Edema was observed only in 
the medial posterior, medial inferior, and lateral posterior regions, but the trend could not be 
confirmed due to the small number of the samples (only in 3 ears). Exudation was distributed 
more evenly through the whole region of the ear canal while the region with the most effect 
was on the medial posterior surface. Signs of ulcers occurred mostly in the medial posterior 
 Table 2. Results of ear canal skin inspections during the first fitting and refitting, and long-term inspections 
in subjects wearing the device successfully
1st fitting Refitting Long-
term31st 
inspection1
2nd 
inspection2
1st
inspection1
2nd
inspection2
Only one sign 23 (52.3) 12 (41.4) 7 (53.8) 1 (12.5) 8 (32.0)
Erythema 6 (13.6) 4 (13.8) 3 (23.1) 0 (0) 3 (12.0)
Edema 0 (0) 0 (0) 3 (23.1) 0 (0) 0 (0)
Exudation 12 (27.3) 6 (20.7) 0 (0) 1 (12.5) 5 (20.3)
Ulcer 5 (11.4) 2 (6.9) 1 (7.7) 0 (0) 0 (0)
Combined signs 10 (22.7) 4 (13.8) 2 (15.4) 2 (25.0) 0 (0)
Erythema + exudation 4 (9.1) 2 (6.9) 0 (0) 1 (12.5) 0 (0)
Erythema + ulcer 2 (4.5) 1 (3.4) 0 (0) 1 (12.5) 0 (0)
Exudation + ulcer 1 (2.3) 1 (3.4) 1 (7.7) 0 (0) 0 (0)
Erythema + exudation + ulcer 1 (2.3) 0 (0) 0 (0) 0 (0) 0 (0)
Edema + exudation + ulcer 1 (2.3) 0 (0) 1 (7.7) 0 (0) 0 (0)
Erythema + edema +
exudation + ulcer 1 (2.3) 0 (0) 0 (0) 0 (0) 0 (0)
Nothing found 11 (25.0) 13 (44.8) 4 (30.8) 5 (62.5) 17 (68.0)
Total inspected 44
(6 missed)
29
(4 missed)
13
(2 missed)
8
(4 missed)
25
(11 missed)
 Figures in parentheses are percentages. Percentages were calculated with respect to the total number 
inspected.
1 The 1st follow-up inspections were done 3 – 5 days after the first fitting or refitting.
2 The 2nd follow-up inspections were done 10 – 14 days after the first fitting or refitting.
3 The long-term inspections were done only for those patients who used the device successfully.
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and medial inferior regions (7 ears for each region), and were also seen considerably in the 
lateral anterior and lateral inferior regions (4 ears for each region). The most common 
location overall was the medial posterior region, especially in the 1st inspection for both the 
first fitting and refitting.
 Ear Canal Skin Integrity as a Factor Determining Continuation of the Wearing 
 Overall, 36 (69.2%) ears were ‘successful’ cases without refitting (24 ears) and with 
refitting (12 ears), and 14 (30.8%) were ‘unsuccessful’ without refitting (11 ears) and with 
refitting (3 ears) ( fig. 4 ). The reasons for interruptions of the wearing after the initial fitting 
(26 ears) were: (1) issues of the ear canal skin (19 ears; 73.1%), which also included 2 ears 
from 2 subjects who initially wore the device on both sides and had problems only on one 
side, but did not want to continue wearing the device unilaterally, (2) migration of the device 
(2 ears; 7.7%), (3) sound quality and feedback (4 ears; 15.4%), and (4) occlusion (1 ear; 
3.8%). Therefore, problems with the ear canal skin were responsible for approximately two 
thirds of the first fitting failures. Among the 19 ears that had issues related to the ear canal 
skin, the associated subjects of 15 of these ears complained of discomfort and had corre-
sponding issues related to the ear canal skin. However, the device had to be removed because 
of issues of the ear canal skin without reports of discomfort in 4 cases (3 ears, grade 2; 1 ear, 
grade 1 and the subject requested that the device be removed). There was no correlation 
between the subjects’ feelings of discomfort and the type of pathological signs in the ear canal.
Inspection Number of samples Total
examinedgrade 0 grade 1 grade 2
First fitting
1st inspection 11 (25.0) 28 (63.6) 5 (11.4) 44
2nd inspection 13 (44.8) 16 (55.2) 0 (0) 29
Refitting
1st inspection 4 (30.8) 8 (61.5) 1 (7.7) 13
2nd inspection 5 (62.5) 3 (37.5) 0 (0) 8
Long-term inspection 17 (68.0) 8 (32.0) 0 (0) 25
Figures in parentheses are percentages. The grade was always 
determined as the highest grade when there was any ambiguity.
 Table 4. Spatial distribution of the pathological signs of the ear canal skin problems
Number of observed samples
location ears with signs
MA MP MS MI LA LP LS LI
Erythema 2 17 4 10 4 4 4 5 28/119 (23.5%)
Edema 0 2 0 2 0 1 0 0 3/119 (2.5%)
Exudation 8 17 7 11 5 7 5 8 40/119 (33.6%)
Ulcer 1 7 1 7 4 2 1 4 21/119 (17.6%)
MA = Medial anterior; MP = medial posterior; MS = medial superior; MI = medial inferior; LA = lateral 
anterior; LP = lateral posterior; LS = lateral superior; LI = lateral inferior.
 Table 3. Grades of pathological 
findings from inspection of the 
ear canal skin
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 Refitting was done for 15 of 26 ears in which the first fitting was interrupted. There was 
no refitting for the other 11 ears (22% of the 50 total investigated ears, ‘unsuccessful’ cases 
without refitting) because the subjects did not want to continue wearing the device. With the 
refitting, 12 ears (80% of the 15 refitted and 24% of the 50 total investigated ears, ‘successful’ 
cases with refitting) were ‘successful’, and wearing the device was interrupted again for 3 
ears (25% of the 15 refitted and 6% of the 50 total investigated ears, ‘unsuccessful’ cases with 
refitting). The reasons for the interruptions even with the refitting were pathological issues 
of the ear canal skin (n = 1), migration (n = 1), and occlusion (n = 1).
 Results of Microbiological Testing 
 Tables 5 and  6 represent bacteria found in microbiological tests of specimens taken from 
the lateral (outer) and medial (inner) sides of the external ear canal. On both sides, coagulase-
negative staphylococci were found most frequently not only in the study group, regardless of 
the duration of wearing the device, but also in the control group. No statistically significant 
difference was found between the different test periods in the study group or between the 
study group and the control group.  Turicella otitidis also had a large number of occurrences 
in specimens from the 1st examination of the study group and the control group, but was 
found less often in the 2nd and 3rd examinations of the study group. A statistically significant 
difference was found only between the 2nd examinations of the study group and the control 
group, for the outer side (p < 0.05, tested by Fisher’s exact test). Other Gram-positive bacteria 
were observed, but their occurrence was much lower than those of coagulase-negative staph-
ylococci and  T. otitidis , without any statistically significant difference between the different 
test periods in the study group or between the study group and the control group. Some 
Successful with refit
(9 ears)
Unsuccessful with refit
(1 ear)
Successful without
refit
(24 ears)
Unsuccessful due to
ear canal pathology
(19 ears)
Unsuccessful
without refit
(9 ears)
1st fit
Successful with refit
(3 ears)
Unsuccessful with refit
(2 ears)
Unsuccessful due to
other clinical issues
(7 ears)
Unsuccessful
without refit
(2 ears)
Refit
 Fig. 4. ‘Successful’ and ‘unsuccessful’ cases of use of the Lyric2 device (n = 50). The problematic conditions 
of the ear canal pathology were responsible for 9 of 11 ‘unsuccessful’ cases without refitting and for 1 of 3 
‘unsuccessful’ cases with refitting. 
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Gram-negative bacteria were found in a few ears of subjects in the control group and in the 
1st examination of the study group but not in the 2nd and 3rd examinations of the study 
group. No statistically significant difference was detected between the different test periods 
in the study group or between the study group and the control group, for any of the Gram-
negative bacteria.
 Table 5. Bacteria observed in microbiological tests at the lateral location (outer side of Lyric2)
Bacteria Study group Control 
group
(n = 10)
1st test
(n = 41)
2nd test
(n = 33)
3rd test
(n = 15)
Gram-positive
Coagulase-negative staphylococci 30 (73.2) 19 (57.6) 10 (66.7) 8 (80.0)
Turicella otitidis 11 (26.8) 3 (9.1) 1 (6.7) 4 (40.0)
Corynebacterium sp. 2 (4.9) 0 (0) 2 (13.3) 1 (10.0)
Staphylococcus aureus 2 (1.9) 0 (0) 0 (0) 1 (10)
Lactobacillus sp. 1 (2.4) 0 (0) 0 (0) 0 (0)
Bacillus sp. 0 (0) 0 (0) 1 (6.7) 0 (0)
Viridans streptococci 0 (0) 0 (0) 0 (0) 1 (10.0)
Micrococcus luteus 0 (0) 0 (0) 0 (0) 1 (10.0)
Gram-negative
Acinetobacter sp. 1 (2.4) 0 (0) 0 (0) 0 (0)
Klebsiella oxytoca 1 (2.4) 0 (0) 0 (0) 0 (0)
Brevundimonas diminuta/vesicularis 1 (2.4) 0 (0) 0 (0) 0 (0)
Flavimonas oryzihabitans 0 (0) 0 (0) 0 (0) 0 (0)
Pseudomonas aeruginosa 0 (0) 0 (0) 0 (0) 0 (0)
Figures in parentheses are percentages.
 Table 6. Bacteria observed in microbiological tests at the medial location (inner side of Lyric2)
Bacteria Study group Control
group
(n = 10)
1st test
(n = 41)
2nd test
(n = 33)
3rd test
(n = 15)
Gram-positive
Coagulase-negative staphylococci 27 (65.9) 16 (48.5) 9 (60.0) 7 (70.0)
Turicella otitidis 10 (24.4) 2 (6.1) 1 (6.7) 3 (30.0)
Corynebacterium sp. 1 (2.4) 1 (3.0) 1 (6.7) 1 (10.0)
Staphylococcus aureus 1 (2.4) 0 (0) 0 (0) 1 (10)
Lactobacillus sp. 1 (2.4) 0 (0) 0 (0) 0 (0)
Bacillus sp. 0 (0) 0 (0) 0 (0) 0 (0)
Viridans streptococci 0 (0) 0 (0) 0 (0) 0 (0)
Micrococcus luteus 0 (0) 0 (0) 0 (0) 1 (10.0)
Gram-negative
Acinetobacter sp. 0 (0) 0 (0) 0 (0) 0 (0)
Klebsiella oxytoca 0 (0) 0 (0) 0 (0) 0 (0)
Brevundimonas diminuta/vesicularis 0 (0) 0 (0) 0 (0) 0 (0)
Flavimonas oryzihabitans 1 (2.4) 0 (0) 0 (0) 0 (0)
Pseudomonas aeruginosa 0 (0) 0 (0) 0 (0) 1 (10.0)
Figures in parentheses are percentages.
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 Figure 5 displays the distribution of the microbiological statuses at the different test 
periods in the study group and in the control group, with classification of the microbiological 
statuses into ‘no bacteria’, ‘Gram-positive’ (i.e. Gram-positive only), and ‘Gram-negative’ 
according to types of bacteria observed. The status of ‘Gram-positive’ occupied the largest 
portion in both the study group (overall, 69.7% for the lateral location and 61.8% for the 
medial location) and the control group (100% for the lateral side and 70% for the medial side). 
The status of ‘Gram-negative’ was found only at the 1st examination and in only 3 samples 
from 2 ears (observed in both the lateral and medial sides for one ear and only in the lateral 
side for the other ear), in the study group. No Gram-negative bacteria were found in the 2nd 
and 3rd examinations in the study group. In the control group, a Gram-negative bacterium of 
 Pseudomonas aeruginosa was observed only in 1 sample (medial side). Comparison between 
different test periods in the study group revealed no development from ‘no bacteria’ to ‘Gram-
positive’ or ‘Gram-negative’ and from ‘Gram-positive’ to ‘Gram-negative’. In the comparison 
between each of the test periods in the study group and the control group, the 2nd test period 
of the study group had a significantly larger portion of ‘no bacteria’ than that of the control 
group, for both outer and inner sides (p < 0.05, Mann-Whitney test).
 Discussion 
 The clinical safety of the first generation of the Lyric device was first assessed by Scherl et 
al. [2011] in a retrospective study. In that study, longitudinal data from 364 subjects wearing 
the device over the course of up to 2 years were gathered and examined, concluding that the 
device was safe if the candidacy guidelines and sizing procedures [Arbogast and Whichard, 
8 (19.5%)
2 (4.9%)
31 (75.6%)
Lateral
1 (2.4%)
29 (70.7%)
Medial
1st examination (n = 41)
21 (63.6%)
Lateral
16 (48.5%)
Medial
2nd examination (n = 33)
17 (51.5%)
12 (36.4%)
10 (66.7%)
Lateral
1 (10%)
10 (66.7%)
Medial
No bacteria
3rd examination (n = 15)
10 (100%)
Lateral
7 (70%)
Medial
Control group (n = 10)
2 (20%)
5 (33.3%)5 (33.3%)
Gram-positive Gram-negative
11 (26.8%)
 Fig. 5. Microbiological status at each of the test periods in the study group and in the control group. 
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2009; Arbogast, 2010] were followed well and the fitters properly trained. In our study with 
the second generation of the device, clinical safety was examined in greater detail, focusing 
primarily on the integrity and microbiological aspects of the ear canal skin. A potential bias in 
our approach of including patients could be the difference in motivation. The subjects who are 
willing to participate in studies to test new technical developments are not necessarily moti-
vated by the same reasons as individuals in need for a solution to their hearing loss.
 Overall, 95% of the inspected ears in the study group showed no (grade 0) or mild (grade 
1) signs with 5% showing grade 2 signs ( table 3 ). These results indicate that the Lyric2 can 
be judged suitable for immediate refitting and continuous use in most cases with respect to 
ear canal skin integrity. The loci of the pathological signs ( table 4 ) indicated that the medial 
posterior region of the ear canal is the most vulnerable area for effects related to its insertion 
or wear. Further improvement in the insertion process and/or design of the device may be 
needed to avoid problematic conditions of the ear canal skin physiology in this region. It has 
been observed that ear canal skin integrity is usually disrupted within the first 30 days of 
wearing the Lyric2. If patients show no such issues after 30 days, they are not likely to develop 
skin alteration later on. As most grade 2 findings are observed around the medial end of the 
device in the bony part of the ear canal, the patients were offered to wear a standard hearing 
aid if the ENT specialist gave clearance and they possessed a hearing aid. Given the motivation 
of most Lyric2 customers for the product (invisibility and no handling), a standard hearing 
aid was not appreciated by most of the subjects.
 Though wearing the Lyric2 does not cause problems of the ear canal skin in most cases, 
this is still considered as the main reason why users must stop wearing the device. Two thirds 
of the unsuccessful cases in the first fitting category (19 out of 26) were caused by issues 
related to the skin of the ear canal. Additionally, some subjects who experienced problematic 
conditions with ear canal skin did not want to continue with a refitting and chose to quit 
wearing the device when the first stage was completed (9 ears from 6 subjects). In the category 
of the ‘unsuccessful’, which included those with refitting (n = 3) and without refitting (n = 11), 
pathological conditions of the ear canal skin were responsible for 71.4% of the unsuccessful 
ears (1/3 ‘unsuccessful’ with refitting, 9/11 ‘unsuccessful’ without refitting; thus, 10 of 14 
ears were categorized as ‘unsuccessful’ due to issues of the ear canal skin).
 However, from the results following refitting, interruption from wearing the device 
reduced the pathological conditions of the ear canal skin after the device was fitted more care-
fully. Among 10 ears (of 6 subjects) that were unsuccessful with the first fitting and were 
subsequently refitted, 9 were successful and only 1 remained unsuccessful. When the 11 
unsuccessful fittings that were not refit are excluded, then only 1/39, approximately 2.5% of 
the investigated ears, was unsuccessful due to ear canal skin problems. Such a result reveals 
that wearing the device can be more successful in the initial fitting if the size of the device is 
chosen more appropriately and the fitting is done more carefully. The outcome of fitting the 
Lyric2 device can be considered to be highly dependent upon the experience and careful 
training of the individual placing the device.
 The incidence of bacteria in the external auditory canal is common even in healthy condi-
tions, and bacteria found in the healthy ears are mostly Gram-positive. In a study by Stroman 
et al. [2001], swab specimens were collected from 164 healthy subjects, and growth of bacteria 
was absent in only 17 subjects. A total of 302 bacteria from external ear swabs of 147 ears 
were found, and 96% of the 302 bacteria were Gram-positive. Staphylococci were present in 
63%. The coryneform bacteria represented 19.5% of the bacteria found, with  T. otitidis 
detected in 12% and  Corynebacterium auris in 2.5%. The third most frequent bacteria 
belonged to the streptococci and enterococci group with 7% of all bacteria. Campos et al. 
[1998] also showed similar results. While several types of Gram-positive bacteria are common 
even in healthy ears, these bacteria are regarded not to be harmful to immune-competent 
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subjects. The existence and abundance of such Gram-positive bacteria in the skin flora of the 
ear canal are determined by the subjects’ living and working environment. The bacteria found 
in the external auditory canal before the placement of the Lyric2 device (1st test in  tables 5 
and  6 ) represent the normal bacterial flora, which can also be observed in microorganisms of 
ears in the control group. Infections of the external auditory canal are polymicrobial in 50% 
of cases and mostly caused by aerobic bacteria, which are Gram-negative. The most often 
isolated bacteria in infected external auditory canals are  P. aeruginosa and  Staphylococcus 
spp. [Brook et al., 1992; Agger and Mardan, 1995; Amigot et al., 2003; Schaefer and Baugh, 
2012; Lee et al., 2013]. These bacteria could not be cultured in any swabs after placement of 
the Lyric2 device in our study.
 Predisposing factors for infections of the external auditory canal are disruption of the 
integrity of the skin due to trauma, dermatologic diseases (i.e. eczema, psoriasis), increase of 
pH [Lee et al., 2013], and increased humidity of the canal causing maceration of the epithelial 
lining [Kowalski, 1988]. An increase in humidity would have favored the growth of Gram-
negative rods, especially  P. aeruginosa [Seyfried and Fraser, 1978; Brook and Coolbaugh, 
1984]. A recent study by Karaca et al. [2013] found significantly more positive bacterial 
cultures in the ear with a hearing aid (61%) as compared to the contralateral ear without a 
hearing aid (3%) in the same subject. The study concluded that occlusion of the canal by 
hearing aids may make the ear canal become a warmer and moist environment and may cause 
change of the pH of cerumen as well, providing favorable conditions for bacteria growth. 
However, in our study, an increase of bacteria after placement of the Lyric2 device or a signif-
icant difference of the bacteria between the study group (i.e. ears with Lyric2) and the control 
group (i.e. ears without Lyric2) was not observed. A possible explanation for the discrepancy 
between the two studies is that occlusion by different types of hearing aids may result in 
different physiological conditions of the ear canal such as temperature, humidity, and pH. For 
instance, the amount of humidity transport through a hearing aid can be different depending 
upon the material of the ear mold or the hearing aid, the size of venting, and the amount of 
occluded space. As the humidity and pH of the ear canal were not measured in either study, 
this possibility cannot be assessed. However, considering the results of our study, it is 
presumed that a significant change of the ear canal environment is not caused by wearing the 
Lyric2. Another possibility is that outpouring of resident bacteria from the deeper skin layers, 
sweat, and sebaceous glands is more significant for the use of conventional hearing aids as in 
the study by Karaca et al. [2013] than for the use of Lyric2 in this study. While the Lyric2 
device is placed deep in the ear canal by trained audiologists and remains in situ for a maximum 
of 120 days until the battery is depleted and the device is replaced, conventional hearing aids 
are inserted and removed frequently on a day-to-day basis. Therefore, risks of contact trans-
mission of microorganisms are smaller for the Lyric2 device. Contact transmission occurs 
when a subject removes/inserts a hearing aid after contacting a contaminated area without 
properly washing her/his hands. Somewhat surprising is that trauma of the ear canal skin, a 
known risk factor for external otitis [Hawke et al., 1984], induced by the Lyric2 device in some 
subjects seems not to induce bacterial growth. Subjects discontinued wearing the Lyric2 
device when there was painful skin irritation.
 Conclusion 
 The main objective of this study was to examine the integrity and microbiological changes 
of the ear canal skin caused by wearing Lyric2, an extended-wear hearing device.
 From the inspection of the integrity of the ear canal skin, the Lyric2 can be judged suitable 
for immediate refitting and continuous use in most cases. Ninety-five percent were judged to 
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be suitable for immediate refitting and continuous use of the device, whereas in 5%, issues 
related to the ear canal skin pathology caused an interruption of use for the ear canal to 
recover.
 Though wearing Lyric2 does not cause problems with ear canal skin pathology in most 
cases, this is still considered to be the main reason for interruption of wearing the device. 
Nevertheless, only 1/10 ears that were unsuccessful in the first fitting due to issues related 
to pathology of the ear canal skin was unsuccessful again in the refitting, and the other 9 ears 
were successful. Considering the fact that refitting was done only with a change of the device’s 
size and/or proper relocation, it is expected that the first fitting can be more successful if it is 
done more carefully using a properly sized device and by developing improved methods to 
minimize trauma during insertion.
 The microbiological tests at three different stages of the use period revealed that occlusion 
by the device does not enhance or prompt the growth of Gram-negative bacteria, which can 
cause ear health-related issues. Therefore, extended wearing of the Lyric2 device can be 
considered safe from a microbiological perspective.
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